AK

Ajit Kumar

Director Director DIN 06498141
DIN 06498141 First appointment Feb 2013 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajit Kumar

Data last updated:

Ajit Kumar was a Director at Alvitas Pharmaceuticals Private Limited (2020–2022) and Director at Medlife Sciences Private Limited (from 2013). The companies operate in Healthcare.

DIN 06498141
Primary Designation Director
Industry Healthcare
First Appointment 27 Feb 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jan 20202020₹20.7 Lakh (FY 2021)Active
Medlife Sciences Private Limited U74120JH2013PTC001041
Director27 Feb 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medlife Sciences Private Limited
Alvitas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ajit Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajit Kumar

Ajit Kumar was first appointed on 27 Feb 2013 as Director at Medlife Sciences Private Limited. The most recent appointment on record is 08 Jan 2020 at Alvitas Pharmaceuticals Private Limited.

Ajit Kumar held 2 earlier board appointments: Alvitas Pharmaceuticals Private Limited (Director, 08 Jan 2020 to 29 Nov 2022); Medlife Sciences Private Limited (Director, from 27 Feb 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available